The new trial makes mRNA vaccines personalized, taking an individual’s unique tumor cells. Seven out of the study’s eight ...

The novel personalized mRNA vaccine also demonstrates the potential for such vaccines in other solid tumor types.

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

Pancreatic cancer pill vaccine shows promising trial results, nearly doubling survival and prompting phase 2 studies, per AACR reports.

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...

Some promising things are happening in health news, including a possible personalized vaccine against pancreatic cancer. Hear ...

There is some promising news for pancreatic cancer research, as medical data show lasting results from the trial of a vaccine ...

Starting this autumn, adults aged 50 and older across the European Union may be able to roll up their sleeve just once and ...

In vitro transcribed mRNA has lived up to its potential as a game-changing disruptive vaccine modality during the COVID-19 ...